Literature DB >> 15661872

Polarized development of memory cell-like IFN-gamma-producing cells in the absence of TCR zeta-chain.

Ludmila Krymskaya1, Wen-Hui Lee, Lingwen Zhong, Chih-Pin Liu.   

Abstract

TCR/CD3 complex-mediated signals play critical roles in regulating CD4(+) Th cell differentiation. In this report, we have examined the in vivo role of a key TCR/CD3 complex molecule zeta-chain in regulating the differentiation of Th cells. We have studied T cells from zeta-chain-deficient mice (zetaKO mice), zeta-chain-bearing mice (zeta(+) mice), and from zetaKO mice expressing a FcRgamma chain transgene (FcRgammaTG, zetaKO mice). Our results demonstrated that, compared with those of control mice, CD4(+) T cells and not CD8(+) T cells from zetaKO mice were polarized into IFN-gamma-producing cells. Some of these IFN-gamma-producing cells could also secrete IL-10. Interestingly, zetaKO mouse T cells produced IFN-gamma even after they were cultured in a Th2 condition. Our studies to determine the molecular mechanisms underlying the polarized IFN-gamma production revealed that the expression level of STAT4 and T-bet were up-regulated in freshly isolated T cells from zetaKO mice. Further studies showed that noncultured zetaKO mice CD4(+) T cells and thymocytes bore a unique memory cell-like CD44(high), CD62L(low/neg) phenotype. Altogether, these results suggest that, in the absence of the zeta-chain, CD4(+) T cells develop as polarized IFN-gamma-producing cells that bear a memory cell-like phenotype. The zeta-chain-bearing T cells may produce a large amount of IFN-gamma only after they are cultured in a condition favoring Th1 cell differentiation. This study may provide important implications for the down-regulation of zeta-chain in T cells of patients bearing a variety of tumors, chronic inflammatory and infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661872     DOI: 10.4049/jimmunol.174.3.1188

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Reduced expression of TCR zeta is involved in the abnormal production of cytokines by peripheral T cells of patients with systemic lupus erythematosus.

Authors:  Keiko Yoshimoto; Yumiko Setoyama; Kensei Tsuzaka; Tohru Abe; Tsutomu Takeuchi
Journal:  J Biomed Biotechnol       Date:  2010-09-06

2.  T cell CD3ζ deficiency enables multiorgan tissue inflammation.

Authors:  Guo-Min Deng; Jessica Beltran; Chen Chen; Cox Terhorst; George C Tsokos
Journal:  J Immunol       Date:  2013-08-26       Impact factor: 5.422

3.  Proximal signaling control of human effector CD4 T cell function.

Authors:  Francesca I Okoye; Sandeep Krishnan; Meena R Chandok; George C Tsokos; Donna L Farber
Journal:  Clin Immunol       Date:  2007-08-09       Impact factor: 3.969

4.  TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues.

Authors:  Zhuoli Zhang; Claire L Gorman; Anna-Chiara Vermi; Claudia Monaco; Andrew Foey; Sally Owen; Parisa Amjadi; Alena Vallance; Catherine McClinton; Federica Marelli-Berg; Pia Isomäki; Andrew Russell; Francesco Dazzi; Timothy J Vyse; Fionula M Brennan; Andrew P Cope
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

5.  All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.

Authors:  Yang-Hau Van; Wen-Hui Lee; Serina Ortiz; Mi-Heon Lee; Han-Jun Qin; Chih-Pin Liu
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

6.  Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection.

Authors:  Abhishek Das; Matthew Hoare; Nathan Davies; A Ross Lopes; Claire Dunn; Patrick T F Kennedy; Graeme Alexander; Helene Finney; Alistair Lawson; Fiona J Plunkett; Antonio Bertoletti; Arne N Akbar; Mala K Maini
Journal:  J Exp Med       Date:  2008-08-11       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.